Market Revenue In Situ Hybridization (ISH) Industry Analysis | Page 3

Bio-Rad Laboratories, Inc., Agilent Technologies, PerkinElmer, Inc., and Merck KGaA. These players are
concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers,
acquisitions, and joint ventures are the need of the hour.
Market Segment:
In Situ Hybridization (ISH) Technology Outlook (Revenue, USD Million, 2014 - 2025)
• Fluorescent In Situ Hybridization (FISH)
• Chromogenic In Situ Hybridization (CISH)
In Situ Hybridization (ISH) Type Outlook (Revenue, USD Million, 2014 - 2025)
• DNA
• RNA
In Situ Hybridization (ISH) Product Outlook (Revenue, USD Million, 2014 - 2025)
• Instruments
• Kits & Probes
• Software
• Services
In Situ Hybridization (ISH) Application Outlook (Revenue, USD Million, 2014 - 2025)
• Cancer
• Cytogenetics
• Developmental Biology
• Infectious Diseases
• Others
In Situ Hybridization (ISH) End-use Outlook (Revenue, USD Million, 2014 - 2025)
• Research & Diagnostic Laboratories
• Contract Research Organizations (CROs)
• Academic Institutes
• Others
In Situ Hybridization (ISH) Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• U.K.